Search research articles
Contact Us
Filters
Showing results (41-50 of 98) with videos related to
Page
of 10
Sort By:
Journal of the National Cancer Institute
|
May 13, 2010
Pediatric phase I trial design using maximum target inhibition as the primary endpoint
Holly Meany, Frank M Balis, Alberta Aikin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2002
Pharmacokinetics of intrathecal gemcitabine in nonhuman primates
Merrill J Egorin, Eleanor G Zuhowski, Cynthia M McCully, et al.
Pediatric Blood & Cancer
|
February 16, 2019
Fundamental problems with pediatric adaptive dosing of carboplatin using nuclear-medicine-based estimates of renal function
Peter C Adamson, Gareth J Veal, Richard B Womer, et al.
Cancer
|
April 1, 2005
A Phase I clinical trial of ixabepilone (BMS-247550), an epothilone B analog, administered intravenously on a daily schedule for 3 days
Sen H Zhuang, Manish Agrawal, Maureen Edgerly, et al.
Cancer Chemotherapy and Pharmacology
|
June 28, 2011
The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primates
Leigh Marcus, Robert Murphy, Elizabeth Fox, et al.
Pediatric Blood & Cancer
|
September 5, 2009
Clinical outcome in children with recurrent neuroblastoma treated with ABT-751 and effect of ABT-751 on proliferation of neuroblastoma cell lines and on tubulin polymerization in vitro
Holly J Meany, Dan L Sackett, John M Maris, et al.
Cancer
|
May 13, 2004
High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma
Brigitte C Widemann, Frank M Balis, Beate Kempf-Bielack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2004
Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates
Kathleen Neville, Robert A Parise, Patrick Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2005
A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer
Peter F Lebowitz, Jennifer Eng-Wong, Brigitte C Widemann, et al.
The Oncologist
|
July 1, 2008
Characteristics and outcome of pediatric patients enrolled in phase I oncology trials
Aerang Kim, Elizabeth Fox, Katherine Warren, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 98) with videos related to
Sort By:
Page
of 10
Journal of the National Cancer Institute
|
May 13, 2010
Pediatric phase I trial design using maximum target inhibition as the primary endpoint
Holly Meany, Frank M Balis, Alberta Aikin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2002
Pharmacokinetics of intrathecal gemcitabine in nonhuman primates
Merrill J Egorin, Eleanor G Zuhowski, Cynthia M McCully, et al.
Pediatric Blood & Cancer
|
February 16, 2019
Fundamental problems with pediatric adaptive dosing of carboplatin using nuclear-medicine-based estimates of renal function
Peter C Adamson, Gareth J Veal, Richard B Womer, et al.
Cancer
|
April 1, 2005
A Phase I clinical trial of ixabepilone (BMS-247550), an epothilone B analog, administered intravenously on a daily schedule for 3 days
Sen H Zhuang, Manish Agrawal, Maureen Edgerly, et al.
Cancer Chemotherapy and Pharmacology
|
June 28, 2011
The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primates
Leigh Marcus, Robert Murphy, Elizabeth Fox, et al.
Pediatric Blood & Cancer
|
September 5, 2009
Clinical outcome in children with recurrent neuroblastoma treated with ABT-751 and effect of ABT-751 on proliferation of neuroblastoma cell lines and on tubulin polymerization in vitro
Holly J Meany, Dan L Sackett, John M Maris, et al.
Cancer
|
May 13, 2004
High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma
Brigitte C Widemann, Frank M Balis, Beate Kempf-Bielack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2004
Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates
Kathleen Neville, Robert A Parise, Patrick Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2005
A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer
Peter F Lebowitz, Jennifer Eng-Wong, Brigitte C Widemann, et al.
The Oncologist
|
July 1, 2008
Characteristics and outcome of pediatric patients enrolled in phase I oncology trials
Aerang Kim, Elizabeth Fox, Katherine Warren, et al.
Page
of 10